{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:16:49Z","timestamp":1790000209157,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUCG-CHS-25\/26-716"],"award-info":[{"award-number":["QUCG-CHS-25\/26-716"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUCG-CHS-25\/26-736"],"award-info":[{"award-number":["QUCG-CHS-25\/26-736"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Male breast cancer (MBC) accounts for less than 1% of all breast cancer cases, yet its incidence is increasing worldwide. Research on MBC remains limited, particularly in Arab populations, where molecular and genetic characteristics are poorly characterized. Improved understanding of MBC biology is essential to support region-specific, biology-driven management strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review was registered in PROSPERO (CRD42024607019) and conducted according to PRISMA guidelines. PubMed, Embase, and Scopus were searched from inception to 28 December 2025. Eligible studies reported MBC cases from Arab countries and included data on molecular subtypes, receptor status, genetic alterations, and\/or clinicopathologic characteristics. Data were extracted independently by four reviewers. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tool, and findings were synthesized narratively with harmonization of tumor grade and stage where applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 9,337 records, 54 studies comprising 1,534 MBC patients met the inclusion criteria. Invasive ductal carcinoma was the predominant histological subtype (92.6%). Among patients with reported intrinsic subtypes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009335), luminal A (45.7%) and luminal B (40.9%) accounted for over 86% of cases, whereas HER2-positive (4.8%) and triple-negative (8.4%) tumors were uncommon and triple-positive disease was rare (0.3%). Receptor status was reported for 1,031 patients, with high ER (71.5%) and PR (71.6%) positivity and low HER2 positivity (12.6%), alongside substantial heterogeneity in testing and reporting. Genetic data were available for 59 patients, most frequently identifying pathogenic truncating\n                      <jats:italic>BRCA2<\/jats:italic>\n                      variants, although BRCA-negative cases were also reported. Surgery was the most reported treatment modality (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009856), predominantly mastectomy-based, while endocrine therapy was frequently used and HER2-targeted therapy was infrequently reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      MBC in Arab populations is predominantly hormone receptor\u2013driven, characterized by luminal subtypes, high ER\/PR positivity, and low HER2 expression. Genetic evidence, though limited, implicates\n                      <jats:italic>BRCA2<\/jats:italic>\n                      as the most frequently reported susceptibility gene. These findings highlight the need for standardized molecular reporting and broader access to receptor profiling and genetic testing to support personalized, region-specific MBC management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00408-0","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:27:51Z","timestamp":1789997271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Male breast cancer in Arab populations: a systematic review of molecular, genetic, and clinicopathologic characteristics"],"prefix":"10.1186","volume":"38","author":[{"given":"Shaden","family":"Abunasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad","family":"Al-Taweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrazad","family":"Elnatsheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Baraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Al-Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waad Rashid","family":"Aldosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baraah A.","family":"Alquran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-956X","authenticated-orcid":false,"given":"Atiyeh M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Al-Haidose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-021-03190-7","volume":"480","author":"S Fox","year":"2022","unstructured":"Fox S, Speirs V, Shaaban AM. Male breast cancer: an update. Virchows Arch. 2022;480:85\u201393. https:\/\/doi.org\/10.1007\/s00428-021-03190-7.","journal-title":"Virchows Arch"},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/0284186X.2017.1418088","volume":"57","author":"MD Lautrup","year":"2018","unstructured":"Lautrup MD, Thorup SS, Jensen V, Bokmand S, Haugaard K, Hoejris I, et al. Male breast cancer: a nation-wide population-based comparison with female breast cancer. Acta Oncol. 2018;57:613\u201321. https:\/\/doi.org\/10.1080\/0284186X.2017.1418088.","journal-title":"Acta Oncol"},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1515\/tjb-2021-0209","volume":"47","author":"DA Odemis","year":"2022","unstructured":"Odemis DA, Celik B, Erciyas SK, Erdogan OS, Tuncer SB, Gultaslar BK, et al. Evaluation of BRCA1\/2 gene mutations in patients with high-risk breast and\/or ovarian cancer in Turkey. Turkish J Biochem. 2022;47:588\u201394. https:\/\/doi.org\/10.1515\/tjb-2021-0209.","journal-title":"Turkish J Biochem"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","volume":"49","author":"FK Al-Thoubaity","year":"2020","unstructured":"Al-Thoubaity FK. Molecular classification of breast cancer: A retrospective cohort study. Ann Med Surg (Lond). 2020;49:44\u20138. https:\/\/doi.org\/10.1016\/j.amsu.2019.11.021.","journal-title":"Ann Med Surg (Lond)"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/BCTT.S340741","volume":"15","author":"A Holler","year":"2023","unstructured":"Holler A, Nguyen-Strauli BD, Frauchiger-Heuer H, Ring A. Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now? Breast Cancer (Dove Med Press). 2023;15:525\u201340. https:\/\/doi.org\/10.2147\/BCTT.S340741.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"408_CR6","doi-asserted-by":"publisher","unstructured":"Obidiro O, Battogtokh G, Akala EO. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics. 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15071796.","DOI":"10.3390\/pharmaceutics15071796"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2009.04.003","volume":"73","author":"L Ottini","year":"2010","unstructured":"Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Male breast cancer. Crit Rev Oncol Hematol. 2010;73:141\u201355. https:\/\/doi.org\/10.1016\/j.critrevonc.2009.04.003.","journal-title":"Crit Rev Oncol Hematol"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.breast.2015.12.001","volume":"26","author":"MH Abreu","year":"2016","unstructured":"Abreu MH, Afonso N, Abreu PH, Menezes F, Lopes P, Henrique R, et al. Male breast cancer: Looking for better prognostic subgroups. Breast. 2016;26:18\u201324. https:\/\/doi.org\/10.1016\/j.breast.2015.12.001.","journal-title":"Breast"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.08.010","volume":"54","author":"S Konduri","year":"2020","unstructured":"Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020;54:8\u201314. https:\/\/doi.org\/10.1016\/j.breast.2020.08.010.","journal-title":"Breast"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","volume":"23","author":"JJ Gao","year":"2018","unstructured":"Gao JJ, Swain SM. Luminal A Breast Cancer and Molecular Assays: A Review. Oncologist. 2018;23:556\u201365. https:\/\/doi.org\/10.1634\/theoncologist.2017-0535.","journal-title":"Oncologist"},{"key":"408_CR11","doi-asserted-by":"publisher","unstructured":"Pierre ES, Georges J, Antoine ES, Ronaldo E, Hampig Raphael K. Breast Cancer in Men: A Systematic Review of the Literature from the Arab World. Int J Oncol Res. 2022;5. https:\/\/doi.org\/10.23937\/2643-4563\/1710042.","DOI":"10.23937\/2643-4563\/1710042"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https:\/\/doi.org\/10.1136\/bmj.n160.","journal-title":"BMJ"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.NAJ.0000450430.97383.64","volume":"114","author":"K Porritt","year":"2014","unstructured":"Porritt K, Gomersall J, Lockwood C. JBI\u2019s Systematic Reviews: Study selection and critical appraisal. Am J Nurs. 2014;114:47\u201352. https:\/\/doi.org\/10.1097\/01.NAJ.0000450430.97383.64.","journal-title":"Am J Nurs"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/XEB.0000000000000064","volume":"13","author":"S Moola","year":"2015","unstructured":"Moola S, Munn Z, Sears K, Sfetcu R, Currie M, Lisy K, et al. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute\u2019s approach. Int J Evid Based Healthc. 2015;13:163\u20139. https:\/\/doi.org\/10.1097\/XEB.0000000000000064.","journal-title":"Int J Evid Based Healthc"},{"key":"408_CR15","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Available from: https:\/\/training.cochrane.org\/handbook."},{"key":"408_CR16","doi-asserted-by":"publisher","unstructured":"Alsayed B, Abdulla HA, Alaskar H, Dhaif A. Male occult triple-negative breast cancer. BMJ Case Rep. 2019;12. https:\/\/doi.org\/10.1136\/bcr-2019-229482.","DOI":"10.1136\/bcr-2019-229482"},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/BD-220073","volume":"42","author":"W Ben Kridis","year":"2023","unstructured":"Ben Kridis W, Lajnef M, Bouattour F, Toumi N, Daoud J, Khanfir A. Prognostic factors of male breast cancer: A monocentric experience. Breast Dis. 2023;42:271\u20135. https:\/\/doi.org\/10.3233\/BD-220073.","journal-title":"Breast Dis"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.11604\/pamj.2020.37.343.23004","volume":"15","author":"M El Fouhi","year":"2020","unstructured":"El Fouhi M, Mesfioui A, Benider A. Male breast cancer: a report of 25 cases. Pan Afr Med J. 2020;15:343. https:\/\/doi.org\/10.11604\/pamj.2020.37.343.23004.","journal-title":"Pan Afr Med J"},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.31557\/APJCP.2025.26.4.1379","volume":"26","author":"M Al-Naqqash","year":"2025","unstructured":"Al-Naqqash M, Kareem TF, Al-Bairmany Y, Al-Serarati W, Alshewered A. Survival Values of Iraqi Male Breast Cancer. Asian Pac J Cancer Prev. 2025;26:1379\u201384. https:\/\/doi.org\/10.31557\/APJCP.2025.26.4.1379.","journal-title":"Asian Pac J Cancer Prev"},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3233\/CBM-190637","volume":"26","author":"M Manai","year":"2019","unstructured":"Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, et al. MARCKS protein overexpression is associated with poor prognosis in male breast cancer. Cancer Biomark. 2019;26:513\u201322. https:\/\/doi.org\/10.3233\/CBM-190637.","journal-title":"Cancer Biomark"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000458156","volume":"40","author":"S Abdeljaoued","year":"2017","unstructured":"Abdeljaoued S, Bettaieb I, Nasri M, Adouni O, Goucha A, El Amine O, et al. Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer. Oncol Res Treat. 2017;40:167\u201372. https:\/\/doi.org\/10.1159\/000458156.","journal-title":"Oncol Res Treat"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.12659\/AJCR.916947","volume":"20","author":"MM Al Awayshih","year":"2019","unstructured":"Al Awayshih MM, Nofal MN, Yousef AJ. Modified Radical Mastectomy for Male Breast Cancer. Am J Case Rep. 2019;20:1336\u20139. https:\/\/doi.org\/10.12659\/AJCR.916947.","journal-title":"Am J Case Rep"},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4314\/mmj.v36i2.8","volume":"36","author":"Z Merad","year":"2024","unstructured":"Merad Z, Belkralladi H, Merad Y, Tou A. Epidemiological, anatomopathological and immunohistochemical profiles of male breast cancer in Sidi Bel Abbes, Algeria (Profiles of male breast cancer). Malawi Med J. 2024;36:115\u20139. https:\/\/doi.org\/10.4314\/mmj.v36i2.8.","journal-title":"Malawi Med J"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/jgyobfe.2016.08.009","volume":"44","author":"K Alaoui Slimani","year":"2016","unstructured":"Alaoui Slimani K, Debbagh A, Sbitti Y, Errihani H, Ichou M. [Male breast cancer in Morocco: Epidemiology and prognostic factors. A report of 140 cases]. Gynecol Obstet Fertil. 2016;44:636\u201340. https:\/\/doi.org\/10.1016\/jgyobfe.2016.08.009.","journal-title":"Gynecol Obstet Fertil"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.11604\/pamj.2022.41.127.28319","volume":"41","author":"M El Fouhi","year":"2022","unstructured":"El Fouhi M, Rahou BH, Mesfioui A, Benider A. Quality of life and epidemiological profile of male breast cancer treated at the university hospital of Casablanca, Morocco. Pan Afr Med J. 2022;41:127. https:\/\/doi.org\/10.11604\/pamj.2022.41.127.28319.","journal-title":"Pan Afr Med J"},{"key":"408_CR26","doi-asserted-by":"publisher","unstructured":"Alouani I, Zerrouki N, Bouziane M, Dikhaye S, Zizi N. Skin involvement as the presenting sign of a male breast cancer. Dermatol Online J. 2020;26. https:\/\/doi.org\/10.5070\/d3262047427.","DOI":"10.5070\/d3262047427"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.11604\/pamj.2013.16.70.2345","volume":"28","author":"K Laabadi","year":"2013","unstructured":"Laabadi K, Jayi S, Alaoui FF, Bouguern H, Chaara H, Melhouf MA, et al. [Breast cancer in men: about 6 cases]. Pan Afr Med J. 2013;28:70. https:\/\/doi.org\/10.11604\/pamj.2013.16.70.2345.","journal-title":"Pan Afr Med J"},{"key":"408_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jnci.2011.10.001","volume":"23","author":"MM Elshafiey","year":"2011","unstructured":"Elshafiey MM, Zeeneldin AA, Elsebai HI, Moneer M, Mohamed DB, Gouda I, et al. Epidemiology and management of breast carcinoma in Egyptian males: experience of a single Cancer Institute. J Egypt Natl Canc Inst. 2011;23:115\u201322. https:\/\/doi.org\/10.1016\/j.jnci.2011.10.001.","journal-title":"J Egypt Natl Canc Inst"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/BD-2010-0323","volume":"33","author":"SF Gilbert","year":"2011","unstructured":"Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, et al. Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. Breast Dis. 2011;33:17\u201326. https:\/\/doi.org\/10.3233\/BD-2010-0323.","journal-title":"Breast Dis"},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1016\/j.lpm.2011.04.010","volume":"40","author":"F Hali","year":"2011","unstructured":"Hali F, Khadir K, Idhammou W, Bensardi FZ, Lefriyekh MR, Benider A, et al. [Cutaneous manifestations of male breast cancer]. Presse Med. 2011;40:e483\u20138. https:\/\/doi.org\/10.1016\/j.lpm.2011.04.010.","journal-title":"Presse Med"},{"key":"408_CR31","first-page":"30","volume":"3","author":"MM El-Habbash","year":"2009","unstructured":"El-Habbash MM, Alwindi AA. Male breast cancer in Tripoli, Libya. Saudi Med J. 2009;3:30.","journal-title":"Saudi Med J"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1471-2407-14-227","volume":"28","author":"AA Soliman","year":"2014","unstructured":"Soliman AA, Denewer AT, El-Sadda W, Abdel-Aty AH, Refky B. A retrospective analysis of survival and prognostic factors of male breast cancer from a single center. BMC Cancer. 2014;28:227. https:\/\/doi.org\/10.1186\/1471-2407-14-227.","journal-title":"BMC Cancer"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1524-4741.2011.01184.x","volume":"18","author":"AN Tawil","year":"2012","unstructured":"Tawil AN, Boulos FI, Chakhachiro ZI, Otrock ZK, Kandaharian L, El Saghir NS, et al. Clinicopathologic and immunohistochemical characteristics of male breast cancer: a single center experience. Breast J. 2012;18:65\u20138. https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01184.x.","journal-title":"Breast J"},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4314\/ahs.v14i2.25","volume":"14","author":"S Guaoua","year":"2014","unstructured":"Guaoua S, Ratbi I, Lyahyai J, El Alaoui SC, Laarabi FZ, Sefiani A. Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer. Afr Health Sci. 2014;14:468\u201371. https:\/\/doi.org\/10.4314\/ahs.v14i2.25.","journal-title":"Afr Health Sci"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s1278-3218(02)00250-0","volume":"6","author":"HE Omari-Alaoui","year":"2002","unstructured":"Omari-Alaoui HE, Lahdiri I, Nejjar I, Hadadi K, Ahyoud F, Hachi H, et al. Male breast cancer. A report of 71 cases. Cancer Radiother. 2002;6:349\u201351. https:\/\/doi.org\/10.1016\/s1278-3218(02)00250-0.","journal-title":"Cancer Radiother"},{"key":"408_CR36","unstructured":"Al-Saleh N, Amir T, Shafi I. Mammary fibromatosis in a male breast. Gulf J Oncolog. 2012;12:77\u201380. https:\/\/europepmc.org\/article\/MED\/22773222Al-Saleh."},{"key":"408_CR37","unstructured":"Al-Saleh N. Bilateral ductal carcinoma in situ (DCIS) in a male breast: a case report. Gulf J Oncolog. 2011;9:68\u201372. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21177213Al-Saleh."},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.lpm.2010.06.001","volume":"39","author":"Y Darouassi","year":"2010","unstructured":"Darouassi Y, Fetohi M, Touiheme N, Ichou MI, Abrouq A, Azendour B. [Nasosinusal metastasis of a breast cancer in a man]. Presse Med. 2010;39:1340\u20132. https:\/\/doi.org\/10.1016\/j.lpm.2010.06.001.","journal-title":"Presse Med"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0973-1482.63561","volume":"6","author":"T El Harroudi","year":"2010","unstructured":"El Harroudi T, Tijami F, El Otmany A, Jalil A. Paget disease of the male nipple. J Cancer Res Ther. 2010;6:95\u20136. https:\/\/doi.org\/10.4103\/0973-1482.63561.","journal-title":"J Cancer Res Ther"},{"key":"408_CR40","first-page":"219","volume":"51","author":"W Troudi","year":"2007","unstructured":"Troudi W, Uhrhammer N, Romdhane KB, Sibille C, Mahfoudh W, Chouchane L, et al. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer? Eur J Histochem. 2007;51:219\u201326.","journal-title":"Eur J Histochem"},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.11604\/pamj.2016.25.205.10366","volume":"25","author":"F Safini","year":"2016","unstructured":"Safini F, Bouchbika Z, Bennani Z, Belkheiri S, Attar HE, Benchakroun N, et al. [Primary large cell neuroendocrine carcinoma of the breast: a rare tumor in humans]. Pan Afr Med J. 2016;25:205. https:\/\/doi.org\/10.11604\/pamj.2016.25.205.10366.","journal-title":"Pan Afr Med J"},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"e71071","DOI":"10.7759\/cureus.71071","volume":"16","author":"MJ Eshaqi","year":"2024","unstructured":"Eshaqi MJ, Al Shamsi SA, Al Saidi AM, Mahesh S. Clinical Insights Into Ductal Carcinoma In Situ in Males: A Report of Two Cases From the Sultanate of Oman. Cureus. 2024;16:e71071. https:\/\/doi.org\/10.7759\/cureus.71071.","journal-title":"Cureus"},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"107367","DOI":"10.1016\/j.ijscr.2022.107367","volume":"96","author":"O Al Laham","year":"2022","unstructured":"Al Laham O, Atia F, Ibrahim D, Shaheen J, Hokouk B. An exceedingly rare simultaneous incidental occurrence of synchronous primary malignancies; Invasive Ductal Carcinoma and Renal Cell Carcinoma in a male - A Case Report. Int J Surg Case Rep. 2022;96:107367. https:\/\/doi.org\/10.1016\/j.ijscr.2022.107367.","journal-title":"Int J Surg Case Rep"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13256-024-04353-1","volume":"18","author":"S Sakhri","year":"2024","unstructured":"Sakhri S, Zemni I, Ayadi MA, Abidi F, Houcine Y, Sghaier S, et al. De novo male breast metastases from nasopharyngeal carcinoma: a case report. J Med Case Rep. 2024;18:36. https:\/\/doi.org\/10.1186\/s13256-024-04353-1.","journal-title":"J Med Case Rep"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.11604\/pamj.2014.19.294.2973","volume":"19","author":"M Sekal","year":"2014","unstructured":"Sekal M, Znati K, Harmouch T, Riffi AA. Apocrine carcinoma of the male breast: a case report of an exceptional tumor. Pan Afr Med J. 2014;19:294. https:\/\/doi.org\/10.11604\/pamj.2014.19.294.2973.","journal-title":"Pan Afr Med J"},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/RLU.0000000000003013","volume":"45","author":"F Marafi","year":"2020","unstructured":"Marafi F, Sasikumar, Alfeeli AM, Thuruthel S. 18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer. Clin Nucl Med. 2020;45:276\u20138.","journal-title":"Clin Nucl Med"},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.47310\/jpms2025140102","volume":"14","author":"AA Marzogi","year":"2025","unstructured":"Marzogi AA, Kalakattawi RMN, Filemban AK, Alwadei AMA. A Case Study of an Inflammatory Breast Cancer in Men-lobular Subtype. J Pioneer Med Sci. 2025;14:8\u201314. https:\/\/doi.org\/10.47310\/jpms2025140102.","journal-title":"J Pioneer Med Sci"},{"key":"408_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12610-010-0116-x","volume":"21","author":"N Sellal","year":"2011","unstructured":"Sellal N, Haddad H, Bouchbika Z, Benchakroun N, Jouhadi H, Tawfiq N, et al. Breast cancer: Male is also concerned. Report on 21 cases. Basic Clin Androl. 2011;21:45\u201351. https:\/\/doi.org\/10.1007\/s12610-010-0116-x.","journal-title":"Basic Clin Androl"},{"key":"408_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10330-011-0918-0","volume":"11","author":"M El-Baradie","year":"2012","unstructured":"El-Baradie M, Salama A, Khorshid O, Ismail H, Attia G, Bahnassy AA. Egyptian male breast carcinoma: patients\u2019 hormonal profile, management and outcome. Chinese-German J Clin Oncol. 2012;11:89\u201398. https:\/\/doi.org\/10.1007\/s10330-011-0918-0.","journal-title":"Chinese-German J Clin Oncol"},{"key":"408_CR50","doi-asserted-by":"crossref","unstructured":"Al Salloom A. Intracystic papillary carcinoma in male breast with high nuclear grade: a case report. J Clin Diagn Res. 2015;9(8):ED04\u2013ED05. PMID: 26435954.","DOI":"10.7860\/JCDR\/2015\/13909.6299"},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.12659\/AJCR.915377","volume":"20","author":"MY Aldossary","year":"2019","unstructured":"Aldossary MY, Alquraish F, Alazhri J. A case of locally advanced breast cancer in a 59-year-old man requiring a modified approach to management. Am J Case Rep. 2019;20:531\u20136. PMID: 30992422.","journal-title":"Am J Case Rep"},{"key":"408_CR52","doi-asserted-by":"publisher","unstructured":"Alharbi A, Algarzaei B, Alrashed R, Alhajri K, Alghamdi A, Alkharashi E, et al. Recurrent malignant fibrous histiocytoma of the male breast: A case report. Int J Surg Open. 2022;48. https:\/\/doi.org\/10.1016\/j.ijso.2022.100566.","DOI":"10.1016\/j.ijso.2022.100566"},{"key":"408_CR53","first-page":"111","volume":"2","author":"F Hammedi","year":"2010","unstructured":"Hammedi F, Trabelsi A, Abdelkrim SB, Abid LBY, Jomaa W, Bdioui A, et al. Mucinous carcinoma with axillary lymph node metastasis in a male breast: A case report. N Am J Med Sci. 2010;2:111\u20133.","journal-title":"N Am J Med Sci"},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1756-0500-4-219","volume":"4","author":"M Bourhafour","year":"2011","unstructured":"Bourhafour M, Belbaraka R, Souadka A, M\u2019Rabti H, Tijami F, Errihani H. Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Res Notes. 2011;4:219. https:\/\/doi.org\/10.1186\/1756-0500-4-219.","journal-title":"BMC Res Notes"},{"key":"408_CR55","doi-asserted-by":"publisher","first-page":"e49710","DOI":"10.7759\/cureus.49710","volume":"15","author":"SN Ekram","year":"2023","unstructured":"Ekram SN, Al Shanbari N, Bin Laswad BM, Alharthi A, Tayeb W, Bahha A. Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. Cureus. 2023;15:e49710. https:\/\/doi.org\/10.7759\/cureus.49710.","journal-title":"Cureus"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1016\/j.radcr.2024.08.110","volume":"19","author":"F Jaheddine","year":"2024","unstructured":"Jaheddine F, Cherif A, Rabilleh M, Lanjeri S, El Houss S, El Bakkari A, et al. Axillary skin lesion: A rare presentation of metastatic male breast cancer. Radiol Case Rep. 2024;19:6053\u20136. https:\/\/doi.org\/10.1016\/j.radcr.2024.08.110.","journal-title":"Radiol Case Rep"},{"key":"408_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1054\/brst.2000.0223","volume":"10","author":"L Temmim","year":"2001","unstructured":"Temmim L, Luqmani YA, Jarallah M, Juma I, Mathew M. Evaluation of prognostic factors in male breast cancer. Breast. 2001;10:166\u201375. https:\/\/doi.org\/10.1054\/brst.2000.0223.","journal-title":"Breast"},{"key":"408_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3969\/j.issn.2095-3941.2012.01.004","volume":"9","author":"W El-Beshbeshi","year":"2012","unstructured":"El-Beshbeshi W, Abo-Elnaga EM. Male breast cancer: 10-year experience at mansoura university hospital in egypt. Cancer Biol Med. 2012;9:23\u20138. https:\/\/doi.org\/10.3969\/j.issn.2095-3941.2012.01.004.","journal-title":"Cancer Biol Med"},{"key":"408_CR59","doi-asserted-by":"publisher","first-page":"103421","DOI":"10.1016\/j.amsu.2022.103421","volume":"75","author":"Y Tahrir","year":"2022","unstructured":"Tahrir Y, Bertal A, Mawhoub S, Makhchoune M, Ibahiouin K, Lakhdar A. A cerebellopontine angle metastatis of a male breast cancer: Case report. Ann Med Surg (Lond). 2022;75:103421. https:\/\/doi.org\/10.1016\/j.amsu.2022.103421.","journal-title":"Ann Med Surg (Lond)"},{"key":"408_CR60","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1016\/j.radcr.2024.08.063","volume":"19","author":"H Zebbakh","year":"2024","unstructured":"Zebbakh H, Sassi S, Adjou N, Omor Y, Latib R, Lamalmi N, et al. Invasive lobular carcinoma of the male breast: A case report. Radiol Case Rep. 2024;19:5758\u201361. https:\/\/doi.org\/10.1016\/j.radcr.2024.08.063.","journal-title":"Radiol Case Rep"},{"key":"408_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5114\/wo.2016.61855","volume":"20","author":"M Soliman","year":"2016","unstructured":"Soliman M, Hetnal M. Male breast cancer: a clinicopathological study of an Egyptian population (Alexandria experience). Contemp Oncol (Pozn). 2016;20:335\u201340. https:\/\/doi.org\/10.5114\/wo.2016.61855.","journal-title":"Contemp Oncol (Pozn)"},{"key":"408_CR62","doi-asserted-by":"publisher","first-page":"103151","DOI":"10.1016\/j.amsu.2021.103151","volume":"72","author":"R Tarrab","year":"2021","unstructured":"Tarrab R, Sabouni R, Jarad L, Mansour N, Saifo MS. Metachronous breast cancer in a male with previous history of liposarcoma: A case report from Syria. Ann Med Surg (Lond). 2021;72:103151. https:\/\/doi.org\/10.1016\/j.amsu.2021.103151.","journal-title":"Ann Med Surg (Lond)"},{"key":"408_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1524-4741.2009.00826.x","volume":"16","author":"A Al Zouman","year":"2010","unstructured":"Al Zouman A, Al Harthi F. Male breast carcinoma with zosteriform metastasis. Breast J. 2010;16:88\u20139. https:\/\/doi.org\/10.1111\/j.1524-4741.2009.00826.x.","journal-title":"Breast J"},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1007\/s11033-020-05703-0","volume":"47","author":"W Ben Kridis-Rejeb","year":"2020","unstructured":"Ben Kridis-Rejeb W, Ben Ayed-Guerfali D, Ammous-Boukhris N, Ayadi W, Kifagi C, Charfi S, et al. Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients. Mol Biol Rep. 2020;47:6507\u201316. https:\/\/doi.org\/10.1007\/s11033-020-05703-0.","journal-title":"Mol Biol Rep"},{"key":"408_CR65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","volume":"102","author":"KD Awadelkarim","year":"2007","unstructured":"Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, et al. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat. 2007;102:189\u201399. https:\/\/doi.org\/10.1007\/s10549-006-9303-z.","journal-title":"Breast Cancer Res Treat"},{"key":"408_CR66","doi-asserted-by":"publisher","first-page":"674965","DOI":"10.3389\/fonc.2021.674965","volume":"11","author":"Y Hamdi","year":"2021","unstructured":"Hamdi Y, Mighri N, Boujemaa M, Mejri N, Ben Nasr S, Ben Rekaya M, et al. Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers. Front Oncol. 2021;11:674965. https:\/\/doi.org\/10.3389\/fonc.2021.674965.","journal-title":"Front Oncol"},{"key":"408_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5152\/ejbh.2019.4928","volume":"16","author":"S Sakhri","year":"2020","unstructured":"Sakhri S, Jaidane O, Bouhani M, Adouni O, Kammoun S, Chargui R, et al. Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity. Eur J Breast Health. 2020;16:77\u201380. https:\/\/doi.org\/10.5152\/ejbh.2019.4928.","journal-title":"Eur J Breast Health"},{"key":"408_CR68","doi-asserted-by":"publisher","unstructured":"Radouan T, Rachida L, Laila R, Ilham J, Mohamed C, Najib B. Intracystic papillary carcinoma of the breast: A rare tumor in man. Imagerie de la Femme. 2013;23:235\u20137. https:\/\/doi.org\/10.1016\/j.femme.2013.10.001.","DOI":"10.1016\/j.femme.2013.10.001"},{"key":"408_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.annpat.2014.02.012","volume":"34","author":"R Kallel","year":"2014","unstructured":"Kallel R, Bahri I, Abid N, Feki J, Mellouli M, Ayadi L, et al. [Mixed breast carcinoma with melanocytic differentiation in a man]. Ann Pathol. 2014;34:115\u20138. https:\/\/doi.org\/10.1016\/j.annpat.2014.02.012.","journal-title":"Ann Pathol"},{"key":"408_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.21608\/ejmr.2023.174543.1293","volume":"5","author":"A Dowidar","year":"2024","unstructured":"Dowidar A, Abdeltwab Z, Semary S, Shaaban SM. Difference in Outcome between Luminal A, Luminal B in Early Stage Breast Cancer Retrospective Study. Egypt J Med Res. 2024;5:61\u201381. https:\/\/doi.org\/10.21608\/ejmr.2023.174543.1293.","journal-title":"Egypt J Med Res"},{"key":"408_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5152\/ejbh.2019.4997","volume":"16","author":"P Pandit","year":"2020","unstructured":"Pandit P, Patil R, Palwe V, Gandhe S, Patil R, Nagarkar R. Prevalence of Molecular Subtypes of Breast Cancer: A Single Institutional Experience of 2062 Patients. Eur J Breast Health. 2020;16:39\u201343. https:\/\/doi.org\/10.5152\/ejbh.2019.4997.","journal-title":"Eur J Breast Health"},{"key":"408_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, et al. Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29:405\u201317. https:\/\/doi.org\/10.1093\/annonc\/mdx651.","journal-title":"Ann Oncol"},{"key":"408_CR73","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjsurg.2022.12.009","volume":"225","author":"A Esposito","year":"2023","unstructured":"Esposito A, Ablah E, Okut H, Tenofsky PL. Characteristics, treatment and outcomes of HER2 positive male breast cancer. Am J Surg. 2023;225:489\u201393. https:\/\/doi.org\/10.1016\/j.amjsurg.2022.12.009.","journal-title":"Am J Surg"},{"key":"408_CR74","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1200\/JCO.19.03120","volume":"38","author":"MJ Hassett","year":"2020","unstructured":"Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020;38:1849\u201363. https:\/\/doi.org\/10.1200\/JCO.19.03120.","journal-title":"J Clin Oncol"},{"key":"408_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.amsu.2016.06.001","volume":"9","author":"RM Staruch","year":"2016","unstructured":"Staruch RM, Rouhani MJ, Ellabban M. The surgical management of male breast cancer: Time for an easy access national reporting database? Ann Med Surg (Lond). 2016;9:41\u20139. https:\/\/doi.org\/10.1016\/j.amsu.2016.06.001.","journal-title":"Ann Med Surg (Lond)"},{"key":"408_CR76","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.clbc.2013.04.003","volume":"13","author":"DK Patten","year":"2013","unstructured":"Patten DK, Sharifi LK, Fazel M. New approaches in the management of male breast cancer. Clin Breast Cancer. 2013;13:309\u201314. https:\/\/doi.org\/10.1016\/j.clbc.2013.04.003.","journal-title":"Clin Breast Cancer"},{"key":"408_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4174\/astr.2020.98.5.215","volume":"98","author":"J Kim","year":"2020","unstructured":"Kim J, Cho J, Lee SK, Choi EK, Kim IR, Lee JE, et al. Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study. Ann Surg Treat Res. 2020;98:215\u201323. https:\/\/doi.org\/10.4174\/astr.2020.98.5.215.","journal-title":"Ann Surg Treat Res"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00408-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00408-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00408-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:27:55Z","timestamp":1789997275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00408-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00408-0","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review of published literature and did not involve human participants, animals, or the collection of primary data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}